Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Seizures × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Xerostomia Due to Radiotherapy (Disorder) 1 Ulcer 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Seizures 1 Renal Insufficiency 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Kidney Failure, Chronic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Advanced/Metastatic Solid Tumors 1 2019 Novel Coronavirus 1

Interventions

perampanel 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04497142 2024-08-05

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

Phase 1/2 Completed

12 enrolled 8 charts

Glioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡